Diabetic Lower Extremity Symposium is organized by Well-Assembled Meetings and will be held during Nov 02 - 03, 2017 at The Joseph B. Martin Conference Center, Boston, Massachusetts, United States of America.
The target audience for this medical event is Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists), Scientists and engineers involved in fundamental or translational biomaterial research R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE. This CME Conference has been approved for a maximum of 9.75 AMA PRA Category 1 Credits.
Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary one and a half day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.
Conference Objectives :
• Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
• Discuss new developments in basic, translational and biomaterial research that impact DLE management
• Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
• Identify possible areas of collaboration between academia and industry